Author: Alicia Löffler
Publisher:
ISBN:
Category :
Languages : en
Pages :

Get Book Here

Book Description

Author: Gerrit Reepmeyer
Publisher: Springer Science & Business Media
ISBN: 379081668X
Category : Business & Economics
Languages : en
Pages : 306

Get Book Here

Book Description
The productivity in pharmaceutical research and development faces intense pres sure. R&D expenditures of the major US and European companies have topped US$ 33 billion in 2003 compared to around US$ 13 billion just a decade ago. At the same time, the number of new drug approvals has dropped from 53 in 1996 to only 35 in 2003. Moreover, the protraction of clinical trials has significantly reduced the effective time of patent protection. The consequences are devastating. Monopoly profits have started to decline and the average costs per new drug have reached a re cord level of close to US$ 1 billion today. As a result, any failure of a new sub stance in the R&D process can lead to considerable losses, and the risks of introduc ing a new drug to the market have grown tremendously. Particularly if a company is highly dependent on just a handful of mega-selling blockbuster drugs, the risks can be even greater. For example, Pfizer generated about 90% of its worldwide revenues in 2002 with just 8 products. Any shortfall of a promising late-stage drug candidate would have left Pfizer with a gaping hole in its product portfolio. In order to deal with these risks, many pharmaceutical companies have started to organize their R&D in partnership. In fact, more than 600 alliances in pharmaceutical R&D are signed every year.

Author: Paul Reynolds
Publisher: Taylor & Francis
ISBN: 113638071X
Category : Business & Economics
Languages : en
Pages : 444

Get Book Here

Book Description
Are you about to undertake a one semester or short course in marketing? If so, 'Marketing: The One Semester Introduction' is the book for you! Written by two of the most experienced and respected authors of the subject in the UK, it is specifically designed for those wanting a rapid and thorough introduction to marketing. This book: · is based on vast teaching experience and classroom testing to ensure that it precisely meets the needs of the business studies or modular marketing student · provides authoritative coverage of the subject, yet avoids becoming entangled in a mass of extra theory that may prove unhelpful for preliminary study · has an international viewpoint that guides the reader to the very heart of contemporary global marketing issues 'Marketing: The One Semester Introduction' provides exactly the right amount of theory and information to ensure rapid and high quality learning. With its succinct and clear style, the book represents an indispensable starting point for students of business studies and marketing.

Author: Jörg Hüser
Publisher: John Wiley & Sons
ISBN: 3527609369
Category : Science
Languages : en
Pages : 362

Get Book Here

Book Description
Backed by leading authorities, this is a professional guide to successful compound screening in pharmaceutical research and chemical biology, including the chemoinformatic tools needed for correct data evaluation. Chapter authors from leading pharmaceutical companies as well as from Harvard University discuss such factors as chemical genetics, binding, cell-based and biochemical assays, the efficient use of compound libraries and data mining using cell-based assay results. For both academics and professionals in the pharma and biotech industries working on small molecule screening.

Author: Ard-Pieter de Man
Publisher: John Wiley & Sons
ISBN: 1118486390
Category : Business & Economics
Languages : en
Pages : 245

Get Book Here

Book Description
A timely and practical guide that helps senior managers design successful strategic partnerships Strategic alliances are increasingly common among modern corporations and a hot topic in today's business schools. Alliance is a sophisticated guide to crafting successful partnerships, offering a combination of carefully designed checklists, up-to-date examples and scenarios from around the world, and the tools needed to ensure that all elements of an alliance are taken into account and fully assessed. Most managers don't have the experience or knowledge to create a functional alliance governance structure. This book fills that knowledge gap with a clear description of the proper implementation process. Ideal for business leaders engaged in building a corporate alliance and business school students Covers all of the available alliance structure, describes the building blocks of alliance design, and defines an effective process for managers constructing alliances Written by a leading expert on the subject who is a member of the Board of Directors of the Association of Strategic Alliance Professionals As the popularity and frequency of corporate strategic alliances grows, Alliance gives business leaders the insight and practical advice they need to ensure their partnerships benefit all parties.

Author: Karen Beynon
Publisher: Woodhead Publishing
ISBN: 9781855734586
Category : Business & Economics
Languages : en
Pages : 188

Get Book Here

Book Description
The pharmaceutical sector offers some of the most exciting financial and business opportunities today. This essential and practical guide gives you all the tools you need to assess such opportunities. The second edition of the respected Pharmaceutical Equities, it has been thoroughly revised and updated to reflect the changes, especially in life sciences, since the first edition. The book is international in outlook, and explains the rules of the game not just for wise investing, but also for understanding how this uniquely complex and highly regulated business works. The authors explain: HOW to evaluate the technology and research and development, as well as the sales potential of ensuing products WHAT key issues will affect and influence companies in the next few years HOW to balance potential high returns on breakthrough products against accompanying risks The book begins with a look at the global pharmaceutical industry, from its history to the structure of present day companies. The second part explores how to analyse and value pharmaceutical and biotechnology companies. The final part deals with trading itself and looks at share price movement and the main equity markets throughout the world. Both practical and comprehensive, this handbook will be essential reading for investors, analysers and corporate planners - and is the ONLY book which will show you how to actually value pharmaceutical companies.

Author: Oliver Gassmann
Publisher: Springer Science & Business Media
ISBN: 3540776362
Category : Business & Economics
Languages : en
Pages : 194

Get Book Here

Book Description
Pharmaceutical giants have been doubling their investments in drug development, only to see new drug approvals to remain constant for the past decade. This book investigates and highlights a set of proactive strategies, aimed at generating sustainable competitive advantage for its protagonists based on value-generating business practices. We focus on three sources of pharmaceutical innovation: new management methods in the drug development pipeline, new technologies as enablers for cutting-edge R&D, and new forms of internationalisation, such as outside-in innovation in the early phases of R&D.

Author: Steven Collins
Publisher: Routledge
ISBN: 1134456093
Category : Business & Economics
Languages : en
Pages : 209

Get Book Here

Book Description
This comparative study looks at the early development of biotechnology in the US and Japan. Drawing on primary and secondary sources it traces the historical roots of recombinant DNA technology, discusses the tensions between regulation and promotional policies and identifies the major actors and strategies that launched biotechnology in both countries. Developing several strands of theory in economic history, science and technology policy, the book proposes a simple model that relates the differences in the two countries' responses to variations in the availability of institutional, financial and organizational resources needed to commercialize the new technology.

Author: Khosrow-Pour, D.B.A., Mehdi
Publisher: IGI Global
ISBN: 1599044196
Category : Technology & Engineering
Languages : en
Pages : 415

Get Book Here

Book Description
"This book presents a wide range of the most current issues related to the planning, design, maintenance, and management of telecommunications and networking technologies and applications in organizations"--Provided by publisher.

Author: Kenneth S Sutherland
Publisher: Elsevier
ISBN: 0080509088
Category : Technology & Engineering
Languages : en
Pages : 334

Get Book Here

Book Description
The total world sales of filtration and separation equipmentand spares are estimated at US$29.5 billion in 2003. Good growth is forecast to continue through to 2009, on the back of the expansion in China, and the fresh and wastewatersegment growth rates, with a CAGR of more than 6%." --Profile of the International Filtration and Separation Industry - Market Prospects to 2009, 5th Edition This revised and updated 5th edition includes increased coverage on the strategic direction of the industry, plus it offers forecasts, analysis and comment on the filtration and separation industry to 2009.The study also outlines the structure of the global industry, assesses market and technological trends, offers market figures and forecasts to 2009 and identifies the major players.